COVID-19 is marked by heightened inflammation and abnormal clotting in the blood vessels, particularly in the lungs, and is believed to contribute to progression to severe disease and death. New trial results show that administering a full dose of a standard blood thinner early to moderately ill hospitalized patients with COVID-19 could halt the thrombo-inflammation…
IMAGE: The growth of unique structure depositions by year in the Protein Data Bank (PDB) and Cambridge Structural Database (CSD) determined by MicroED or related 3D electron diffraction techniques. Depositions into… view more Credit: Bruhn, J. et al. Front. Mol. Biosci., 2021 8, 354. CAMBRIDGE July 13, 2021 – To date, solving structures of potential therapeutics…
Bacterial vaginosis is the most common and recurrent gynecological condition affecting nearly 30% of women between the ages of 15 and 44, according to the U.S. Centers for Disease Control and Prevention. A University of Arizona Health Sciences-led study recently identified a specific bacteria family and uncovered how it contributes to bacterial vaginosis, paving the…
In early March 2020, the University of Washington became the first four-year U.S. university to transition to online-only classes due to the COVID-19 pandemic. Many researchers predicted severe consequences of these physical distancing measures. To understand how this change affected college students’ mental health, UW researchers surveyed 147 UW students over the 2020 spring quarter,…
The COVID-19 pandemic and the situations of stress and sadness associated with it have not significantly increased the prevalence of depression and anxiety among participants in the Brazilian Longitudinal Study of Adult Health (ELSA-Brazil) who live in the city of São Paulo. ELSA-Brazil has been monitoring the overall health of 15,000 civil servants at six…
In a new study of adults from the general population who were infected with COVID-19 in 2020, more than a quarter report not having fully recovered after six to eight months. Those findings are described this week in the open-access journal PLOS ONE by Milo Puhan and colleagues at the University of Zurich, Switzerland. While…
“Americans who have been fully vaccinated do not need a booster shot at this time,” the statement said, adding, “We are prepared for booster doses if and when the science demonstrates that they are needed.” The move may make good business sense for Pfizer-BioNTech. Since the onset of the pandemic, the partner companies have pursued…
The database indicates only one possible death of a recipient of the Johnson & Johnson shot from Guillain-Barré syndrome. But the man, a 57-year-old from Delaware, had also had a heart attack and a stroke in the past four years, raising questions about what led to his death in April. Even though it requires only…
In the United States, nearly 50 percent of all residents are fully vaccinated. But in India, only about 5 percent of the population is fully vaccinated. In much of Africa, fewer than 1 percent of people are vaccinated. The concern is that the longer large parts of the world remain unvaccinated, the greater the risk…
Johnson & Johnson’s beleaguered Covid-19 vaccine may be associated with a small increased risk of Guillain–Barré syndrome, a rare but potentially serious neurological condition, federal officials said on Monday. The Food and Drug Administration has added a warning about the potential side effect to its fact sheets about the vaccine. The risk appears to be…